High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers

Kristiina Iljin, Paula Vainio, Kirsi Ketola, M. Björkman, Pekka Kohonen, John Mpindi, Vidal Fey, T. Mirtti, K. Alanen, Merja Perälä, Olli Kallioniemi

Research output: Contribution to conferenceConference articleScientific

Original languageEnglish
Publication statusPublished - 2010
MoE publication typeNot Eligible
EventBIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010 - Beijing International Convention Center, Beijing, China
Duration: 23 Oct 201026 Oct 2010

Conference

ConferenceBIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010
CountryChina
CityBeijing
Period23/10/1026/10/10

Cite this

Iljin, K., Vainio, P., Ketola, K., Björkman, M., Kohonen, P., Mpindi, J., ... Kallioniemi, O. (2010). High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers. Paper presented at BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010, Beijing, China.
Iljin, Kristiina ; Vainio, Paula ; Ketola, Kirsi ; Björkman, M. ; Kohonen, Pekka ; Mpindi, John ; Fey, Vidal ; Mirtti, T. ; Alanen, K. ; Perälä, Merja ; Kallioniemi, Olli. / High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers. Paper presented at BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010, Beijing, China.
@conference{3e9b754730814de8ae44fd9bfa519b26,
title = "High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers",
author = "Kristiina Iljin and Paula Vainio and Kirsi Ketola and M. Bj{\"o}rkman and Pekka Kohonen and John Mpindi and Vidal Fey and T. Mirtti and K. Alanen and Merja Per{\"a}l{\"a} and Olli Kallioniemi",
year = "2010",
language = "English",
note = "BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010 ; Conference date: 23-10-2010 Through 26-10-2010",

}

Iljin, K, Vainio, P, Ketola, K, Björkman, M, Kohonen, P, Mpindi, J, Fey, V, Mirtti, T, Alanen, K, Perälä, M & Kallioniemi, O 2010, 'High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers' Paper presented at BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010, Beijing, China, 23/10/10 - 26/10/10, .

High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers. / Iljin, Kristiina; Vainio, Paula; Ketola, Kirsi; Björkman, M.; Kohonen, Pekka; Mpindi, John; Fey, Vidal; Mirtti, T.; Alanen, K.; Perälä, Merja; Kallioniemi, Olli.

2010. Paper presented at BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010, Beijing, China.

Research output: Contribution to conferenceConference articleScientific

TY - CONF

T1 - High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers

AU - Iljin, Kristiina

AU - Vainio, Paula

AU - Ketola, Kirsi

AU - Björkman, M.

AU - Kohonen, Pekka

AU - Mpindi, John

AU - Fey, Vidal

AU - Mirtti, T.

AU - Alanen, K.

AU - Perälä, Merja

AU - Kallioniemi, Olli

PY - 2010

Y1 - 2010

M3 - Conference article

ER -

Iljin K, Vainio P, Ketola K, Björkman M, Kohonen P, Mpindi J et al. High-throughput compound and siRNA screening to identify novel treatment options for ERG oncogene positive prostate cancers. 2010. Paper presented at BIT’s 8th Annual Congress of International Drug Discovery Science and Technology, IDDST 2010, Beijing, China.